Trulieve Cannabis (TCNNF) Shares Outstanding (Weighted Average) (2020 - 2026)
Trulieve Cannabis (TCNNF) recorded quarterly Shares Outstanding (Weighted Average) of $192.5 million in Q1 2026, up 0.64% quarter-over-quarter from $191.3 million in Q4 2025, and up 0.74% on a YoY basis from $191.1 million in Q1 2025.
Trulieve Cannabis (TCNNF) Shares Outstanding (Weighted Average) (2020 - 2026) Analysis & Trends
Trulieve Cannabis' Shares Outstanding (Weighted Average) history runs 7 years deep, the most recent figure standing at $192.5 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Weighted Average) rose 0.74% year-over-year to $192.5 million; the TTM figure through Mar 2026 stood at $192.5 million (up 0.74% YoY), while the FY2025 annual figure was $191.3 million, up 0.7% from the prior year.
- Shares Outstanding (Weighted Average) was $192.5 million for Q1 2026 at Trulieve Cannabis, up from $191.3 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $192.5 million in Q1 2026 to a low of $187.1 million in Q1 2022.
- Historically, Shares Outstanding (Weighted Average) has averaged $189.6 million across 5 years, with a median of $189.5 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Weighted Average) surged 56.02% in 2022, then advanced 0.19% in 2023.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $188.0 million in 2022, then rose by 0.52% to $189.0 million in 2023, then gained by 0.54% to $190.0 million in 2024, then climbed by 0.7% to $191.3 million in 2025, then gained by 0.64% to $192.5 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $192.5 million (Q1 2026), $191.3 million (Q4 2025), and $191.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 1.16 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 422.10 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 43.50 Mn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 100.50 Mn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 5.11 Bn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 497.70 Mn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 166.20 Mn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 64.74 Mn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 88.01 Mn |
| 10 | Trulieve Cannabis | - | - | 170.08 Mn | 192.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 192.54 Mn |
| Dec 31, 2025 | 191.32 Mn |
| Sep 30, 2025 | 191.20 Mn |
| Jun 30, 2025 | 191.20 Mn |
| Mar 31, 2025 | 191.13 Mn |
| Dec 31, 2024 | 189.99 Mn |
| Sep 30, 2024 | 190.00 Mn |
| Jun 30, 2024 | 189.91 Mn |
| Mar 31, 2024 | 189.49 Mn |
| Dec 31, 2023 | 188.97 Mn |
| Sep 30, 2023 | 188.96 Mn |
| Jun 30, 2023 | 188.98 Mn |
| Mar 31, 2023 | 188.90 Mn |
| Dec 31, 2022 | 188.00 Mn |
| Sep 30, 2022 | 188.60 Mn |
| Jun 30, 2022 | 187.17 Mn |
| Mar 31, 2022 | 187.05 Mn |
| Dec 31, 2021 | 139.37 Mn |
| Sep 30, 2021 | 128.15 Mn |
| Jun 30, 2021 | 120.35 Mn |